| 1 | [SID24788372] | Active | Potency | 2.8184 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 2 | [SID24788372] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 3 | [SID24788372] | Active | Potency | 3.1623 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 4 | [SID24788372] | Active | Potency | 3.5481 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 5 | [SID24788372] | Active | Potency | 3.9811 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 6 | [SID24788372] | Active | Potency | 3.9811 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 7 | [SID24788372] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID24788372] | Active | Potency | 4.4668 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 9 | [SID24788372] | Active | Potency | 4.6109 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 10 | [SID24788372] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID24788372] | Active | IC50 | 7.654 | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID651553, Type: confirmatory] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | IC50 | 7.654 [uM] | | BioAssay | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 651553 | | BioAssay type | confirmatory | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 12 | [SID24788372] | Active | IC50 | 7.654 | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID651553, Type: confirmatory] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | IC50 | 7.654 [uM] | | BioAssay | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 651553 | | BioAssay type | confirmatory | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 13 | [SID24788372] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 14 | [SID24788372] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 15 | [SID24788372] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID24788372] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 17 | [SID24788372] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 18 | [SID24788372] | Active | Potency | 21.3313 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | Potency | 21.3313 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 19 | [SID24788372] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 20 | [SID24788372] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID24788372] | Active | | | Counter screen for compounds that modulate transient receptor potential cation channel C6 (TRPC6) [AID488924, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Counter screen for compounds that modulate transient receptor potential cation channel C6 (TRPC6) | | AID | 488924 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID24788372] | Active | | | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity [AID504408, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity | | AID | 504408 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID24788372] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID24788372] | Active | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID24788372] | Active | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID24788372] | Active | | | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation [AID1285, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation | | AID | 1285 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 27 | [SID24788372] | Active | | | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation [AID1285, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation | | AID | 1285 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 28 | [SID24788372] | Active | | | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation [AID1285, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation | | AID | 1285 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 29 | [SID24788372] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 30 | [SID24788372] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 31 | [SID24788372] | Active | | | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex [AID588475, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588475 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 32 | [SID24788372] | Active | | | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex [AID588475, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588475 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 33 | [SID24788372] | Active | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Retest of Primary Hits [AID1917, Type: other] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Retest of Primary Hits | | AID | 1917 | | BioAssay type | other | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 34 | [SID24788372] | Active | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen [AID1918, Type: screening] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen | | AID | 1918 | | BioAssay type | screening | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 35 | [SID24788372] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 36 | [SID24788372] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 37 | [SID24788372] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 38 | [SID24788372] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 39 | [SID24788372] | Active | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 40 | [SID24788372] | Active | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 41 | [SID24788372] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 42 | [SID24788372] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 43 | [SID24788372] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 44 | [SID24788372] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 45 | [SID24788372] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID651612, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 651612 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 46 | [SID24788372] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 47 | [SID24788372] | Active | | | High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6) [AID2550, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6) | | AID | 2550 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 48 | [SID24788372] | Active | | | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay [AID588493, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay | | AID | 588493 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 49 | [SID24788372] | Active | | | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. [AID2153, Type: screening] | unnamed protein product [Aspergillus oryzae] [gi:83774548] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. | | AID | 2153 | | BioAssay type | screening | | Target | unnamed protein product [Aspergillus oryzae] [gi:83774548] | | PubMed | | | Data Table |  |
|
| 50 | [SID24788372] | Active | | | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. [AID2153, Type: screening] | unnamed protein product [Aspergillus oryzae] [gi:83774548] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24788372 | | CID | 1782242 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. | | AID | 2153 | | BioAssay type | screening | | Target | unnamed protein product [Aspergillus oryzae] [gi:83774548] | | PubMed | | | Data Table |  |
|